Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Fabry Disease: Current Perspectives on Diagnosis and Management Strategies.
Journal: Advances in kidney disease and health
Published: January 07, 2026
The Alternative Complement Pathway in IgA Nephropathy: A Podcast for Advanced Practice Providers.
Journal: Advances in therapy
Published: November 06, 2025
The Impact of Renin-Angiotensin Aldosterone System Inhibitors in IgA Nephropathy: A Meta-Analysis of Randomized Controlled Trials.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: July 15, 2025
Correction: Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panel.
Journal: PloS one
Published: April 22, 2025
Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: October 09, 2024
Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists.
Journal: Journal of primary care & community health
Published: August 15, 2024
Utilization of Potassium Binders for the Management of Hyperkalemia in Chronic Kidney Disease: A Position Statement by US Nephrologists.
Journal: Advances in kidney disease and health
Published: June 18, 2024
Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan.
Journal: Advances in therapy
Published: May 29, 2024
Association of Different Definitions of Erythropoiesis-Stimulating Agent Hyporesponsiveness with Major Adverse Cardiovascular Events: Insights from ASCEND-D.
Journal: Kidney360
Published: May 13, 2024
Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort study.
Journal: Clinical kidney journal
Published: November 15, 2023
Last Updated: 09/26/2026